February 5, 2020
Kirsten Nyrop, PhD, will lead a one-year qualitative research study on how clinicians can discuss weight management with breast cancer survivors in an effort to decrease racial disparities in obesity-related comorbidities that can affect survivorship.
February 4, 2020
An experimental blood test accurately detected HPV-linked head and neck cancer recurrence and confirmed when patients remained cancer-free.
February 3, 2020
Tumors can create a hostile environment for cancer-fighting immune cells. In a new study, University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a method for engineering immune cells to improve their survival and proliferation, even within a hostile tumor. Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, report in the journal Nature …
January 30, 2020
A discovery by University of North Carolina Lineberger Comprehensive Cancer Center researchers could allow scientists to fine-tune genetically engineered immune cells to heighten their killing power against tumors or to decrease their activity level in the case of severe side effects. In a study published in Cancer Cell, researchers led by UNC Lineberger’s Gianpietro Dotti, …
January 16, 2020
Comparison shopping for airfare, a TV, or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA Oncology. Trevor Royce, MD, MPH, MS, of the University of North Carolina Lineberger Comprehensive Cancer Center, is …
January 14, 2020
The Conquer Cancer Foundation of the American Society of Clinical Oncology, in conjunction with the Breast Cancer Research Foundation, has presented a Young Investigator Award to UNC Lineberger’s Emily Ray, MD, MPH. Ray, who is an assistant professor of medicine in the division of hematology/oncology at UNC School of Medicine, will use the one year, …
January 14, 2020
An early-stage clinical study investigating a method of boosting the body’s defenses against two blood cancers found the drug pomalidomide could be safely added to conventional treatments, and help improve immune function. University of North Carolina Lineberger Comprehensive Cancer Center researcher Joshua Zeidner, MD, assistant professor in the UNC School of Medicine Division of Hematology/Oncology, …
January 13, 2020
A study led by UNC Lineberger's Tim Gershon, MD, PhD, shows new evidence to explain how drug resistance develops in a major subtype of medulloblastoma.
December 19, 2019
The American Society of Clinical Oncology has elected UNC Lineberger Comprehensive Cancer Center’s Lisa A. Carey, MD, FASCO, to its Board of Directors.
December 16, 2019
In 2019, nearly 2 million Americans will receive a cancer diagnosis and more than 600,000 will die of cancer, according to the American Cancer Society. Cancer diagnoses and deaths are disproportionately high among people who live in rural counties, have a low socioeconomic status, and are members of underserved racial and ethnic groups. The Cancer …